Apple Health+ / Apple health coach (Project Mulberry) CAIHL draft report

Apple Health+ / Apple health coach (Project Mulberry): CAIHL reassessment

September 8, 2026. Published AI-assisted draft.

Apple Health+ / Project Mulberry remains an unscored watch-list concept in this review. No official named deployment was verified. Controls from the existing Apple Health app cannot be assumed to apply to this proposed coach.

Scope and agency posture

Unverified Apple Health+ / Project Mulberry watch-list concept, distinct from the shipped Apple Health app and third-party apps with similar names.

Posture: Unclear, named deployment unverified.

Axis: Unscored in current comparisons. Historical axis: 70/100. No official named deployment verified in this pass. This is a scope change, not a numerical downgrade.

Sources and documented findings

• The baseline explicitly says 70 is a pre-launch placeholder based on reporting, not a product finding.

• A focused Apple-domain search did not recover an official announcement of this named coach. A targeted read of Apple's health overview documented existing health and fitness features, not the proposed named service. Search absence is not proof that no release exists. https://www.apple.com/health/

Patient authority

Inference from the documented workflow: No product-specific authority, redirection or output controls were established. Existing Apple Health controls cannot be transferred to the reported concept.

Critical capacity

Editorial assessment: The reported ability to interpret personal health information is only design intent. No reviewed coach interaction establishes source checking or support for challenging care decisions.

Informed control

Editorial assessment: Subscription, cloud processing and privacy claims for this concept remain unverified. Do not borrow assurances from other Apple products.

Assessment and limits

A numeric consumer-product placement conflicts with the baseline's own unassessable status. This is a comparability correction, not a negative agency judgment.

Confidence: Low, no verified named deployment.

Remaining uncertainty: Existence, availability and all product-specific control arrangements remain unresolved

Published documentation is evidence of stated conditions, not proof of actual implementation. Unknowns did not receive automatic negative points. Funding, sponsorship, and public code do not determine agency by themselves.

Review provenance

• Reviewer/model: OpenAI Codex / GPT-6.
• Method: Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.
• Human review: Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.
• Earlier review: 2026-06-12. Historical assessment. Earlier claims are not automatically reverified by this publication.